Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.61 USD | -0.97% | +6.86% | +74.44% |
May. 15 | Spyre Therapeutics, Inc. Announces Board Changes | CI |
May. 13 | Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating | MT |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.